2012
DOI: 10.1016/b978-0-12-396962-0.00001-x
|View full text |Cite
|
Sign up to set email alerts
|

Stapled Peptides for Intracellular Drug Targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
400
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 396 publications
(413 citation statements)
references
References 57 publications
4
400
0
1
Order By: Relevance
“…All-hydrocarbon peptide stapling is a powerful cross-linking system that effectively stabilizes the α-helical conformation of a peptide by incorporating an all-hydrocarbon tether formed via ruthenium-mediated ringclosing olefin metathesis. [17][18][19][20][21] For the hydrophobic face, we placed the oct-4-enyl staple between position 2 and 6 ( Figure 1). For the hydrophillic face, a lysine was incorporated at positions 1, 4, and 7 each, which reside on the opposite side of the staple.…”
Section: Resultsmentioning
confidence: 99%
“…All-hydrocarbon peptide stapling is a powerful cross-linking system that effectively stabilizes the α-helical conformation of a peptide by incorporating an all-hydrocarbon tether formed via ruthenium-mediated ringclosing olefin metathesis. [17][18][19][20][21] For the hydrophobic face, we placed the oct-4-enyl staple between position 2 and 6 ( Figure 1). For the hydrophillic face, a lysine was incorporated at positions 1, 4, and 7 each, which reside on the opposite side of the staple.…”
Section: Resultsmentioning
confidence: 99%
“…2,3 Proteomimetics, and stapled peptides in particular, are proving useful for targeting PPIs. 4,5 The main focus of this review is the design, synthesis, and application of stapled peptides as molecular probes to disrupt PPIs. …”
Section: Introductionmentioning
confidence: 99%
“…Even though high biodegradability, low bioavailability and low cellular uptake may be some of the limitations of peptide drugs, they can benefit from novel synthetic strategies for enhancing their drug-like properties (Pandey et al 2009;Vlieghe et al 2010). Currently, modifications that a prospective peptide drug candidate can undergo to enhance their efficacy include peptide stapling (Verdine and Hilinski 2012), backbone replacement (Fernández-Llamazares et al 2014), non-natural amino acid incorporation, pseudo peptide bonds, cyclization (Gentilucci et al 2010), conjugation (Gauthier and Klok 2008;Ahrens et al 2012) and so on.…”
Section: Introductionmentioning
confidence: 99%